International Journal of Drug Delivery Technology
Volume 14, Issue 2

Development of Enteric-Coated Tablet with a Unique Combination of Therapeutic and Nutraceutical Actives to Treat Colitis

Manish Kumar Gupta1, Ketaki Dhane2*, Chandraprabhu Jangme2, Abhinandan Patil2

1Jaipur School of Pharmacy, Maharaj Vinayak Global University, Jaipur, Rajasthan, India.

2D.Y. Patil College of Pharmacy, D.Y. Patil Education Society (Deemed to be University), Kolhapur, Maharashtra, India 

Received: 04th May, 2023; Revised: 25th May, 2024; Accepted: 08th June, 2024; Available Online: 25th June, 2024 

ABSTRACT

The primary objectives of the current investigation were to design and characterize enteric-coated oil of ginger tablets in coconut water powdered form as a therapy for ulcerative colitis. One source that is both anti-inflammatory and high in electrolytes is a combination of ginger oil and powdered coconut water. By reducing inflammation and improving electrolyte and water balance, this combination will hasten the healing process. Starch 1500, microcrystalline cellulose, and ethyl cellulose were used to create enteric-coated tablets of ginger oil alone and in combination with coconut water powder. The results corroborated the findings that there were no unique interactions between any of the substances, as demonstrated by the examination of both tablets, which included morphology, micrometric features, and fourier transform infrared (FTIR) spectroscopic capabilities. We studied the dissolving characteristics of coated tablets at pH 1.2, 6.8, and 7.4 in a buffer. Quantification of gingerol was accomplished by use of reverse-phase high-performance liquid chromatography (RP-HPLC) technology. The selected formulation’s therapeutic efficacy was lastly confirmed using a colitis model generated by 2,4,6-trinitrobenzene sulfonic acid. Tablets containing either ginger oil or a powdered combination of ginger oil as well as coconut water were compared in the research. Myeloperoxidase, lipid peroxidase, and histological assessment were calculated using the colitis model. The colon/ body weight ratio was also measured. Research on animals has shown that a combination of the coated oil of ginger and the oil of coconut tablets, as opposed to ginger oil tablets alone, considerably improved the sick conditions in Wistar rats. The gain in weight and clinical improvements in the macroscopic and microscopic factors of induced colitis served as evidence of this. These results demonstrate the potential of coated tablets formulated with coconut water powder for the targeted delivery of ginger oil to the colon as well as for the improvement of colon health through the balance of micronutrients and water content. It is not practical to increase the dosage to compensate for metabolic loss while using ginger oil because of its strong taste and strength. Therefore, the formulation of choice is enteric coating. As enteric coating tablets target the intestine as the site of action, it is possible to use less potent ginger oil. Due to the inclusion of coconut water powder, the formulation not only helps cure the illness state but also promotes and supports a speedy recovery.

Keywords: Ginger oil, Coconut water, Enteric coating.

International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.2.42

How to cite this article: Gupta MK, Dhane K, Jangme C, Patil A. Development of Enteric-Coated Tablet with a Unique Combination of Therapeutic and Nutraceutical Actives to Treat Colitis. International Journal of Drug Delivery Technology. 2024;14(2):886-894.

REFERENCES

  1. Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet and JC. Ulcerative colitis Ryan HHS Public Lancet. 2017;389(1):139–48. Available from: https://doi. org/10.1016/S0140-6736(16)32126-2
  2. Jung Differential diagnosis of inflammatory bowel disease: What is the role of colonoscopy? Clin Endosc. 2012;45(3):254–62.
  3. Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel J Med Life. 2019;12(2):113–22. Available from: https://doi.org/10.5946/ce.2012.45.3.254
  4. Travis SPL, Stange EF, Lémann M, Øresland T, Bemelman WA, Chowers Y, et al. European evidence-based Consensus on the management of ulcerative colitis: Current J Crohn’s Colitis.2008;2(1):24–62. Available from:https://doi.org/10.1016/j. crohns.2007.11.002
  5. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inf lammatory bowel disease: Controversies, consensus, and Gut. 2006;55(6):749–53. Available from: https://doi.org/10.1136%2Fgut.2005.082909
  6. Raj VS, Mou H, Smits SL, Dekkers DHW, Müller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature [Internet]. 2013 Mar 14;495(7440):251–4. Available from: https://pubmed.ncbi. nih.gov/23486063. Available from: https://doi.org/10.1038/ nature12005
  7. Gupta, Manish Kumar, ketaki Dhane, Birendra Shrivasttva, Supriya Hyam, Sujit Nagare AP. A Review on Metabolic Syndrome. Int J Health Sci (Qassim). 2022;6(S2)(1):5866–5875. Available from: https://doi.org/10.53730/ijhs.v6nS2.6507
  8. Ioniță-Mîndrican CB, Ziani K, Mititelu M, Oprea E, Neacșu SM, Moroșan E, et al. Therapeutic Benefits and Dietary Restrictions of Fiber Intake: A State of the Art Nutrients. 2022;14(13):100–25. Available from: https://doi.org/10.3390/ nu14132641
  9. Lim HH, Yang SJ, Kim Y, Lee M, Lim Combined treatment of mulberry leaf and fruit extract ameliorates obesity-related inflammation and oxidative stress in high fat diet-induced obese mice. J Med Food. 2013;16(8):673–80. Available from: https://doi. org/10.1089/jmf.2012.2582
  10. Kendall WA, Stringer WC. Physiological aspects of clover. Clover Sci 2015;31(3):111–59. Available from: https:// doi.org/10.2134/agronmonogr25.c4
  11. Sorathiya A, Vyas S, Bhat A clinical study on the role of ama in relation to Grahani Roga and its management by Kalingadi Ghanavati and Tryushnadi Ghrita. AYU (An Int Q J Res Ayurveda). 2010;31(4):451. Available from: https://doi. org/10.4103/0974-8520.82041
  12. Patel M, Patel K, Gupta Effects of Ayurvedic treatment on forty-three patients of ulcerative colitis. AYU (An Int Q J Res Ayurveda). 2010;31(4):478. Available from: https://doi. org/10.4103/0974-8520.82046
  13. Pooja B, Bhatted S. Ayurvedic management of Pravahika – A case report. AYU (An Int Q J Res Ayurveda). 2015;36(4):410.
  14. Mao QQ, Xu XY, Cao SY, Gan RY, Corke H, Beta T, et al. Bioactive compounds and bioactivities of ginger (zingiber officinale roscoe). 2019;8(6):1–21. Available from: https:// doi.org/10.4103/0974-8520.190701
  15. Nikkhah Bodagh M, Maleki I, Hekmatdoost A. Ginger in gastrointestinal disorders: A systematic review of clinical Food Sci Nutr. 2019;7(1):96–108. Available from: https://doi. org/10.1002/fsn3.807
  16. Ballester P, Cerdá B, Arcusa R, Marhuenda J, Yamedjeu K, Zafrilla P. Effect of Ginger on Inflammatory Diseases. 2022;27(21). Available from: https://doi.org/10.3390/ molecules27217223
  17. Manish Kumar Gupta1, Ketaki Dhane 2* B, Shrivasttva3, Supriya Hyam4, Sujit Nagare5, Arvind Shinde6 Cell-Based Phenotypic Approaches in Drug Discovery. Int J Pharm Pharm Res. 2022;23(3):309–21.
  18. Manish Kumar Gupta, Ketaki Dhane, Birendra Shrivasttva, Supriya Hyam, Sujit Evaluation of the Impact of the Ayurvedic Formulation” Amruthotharam” on Obesity- Related Diabetic and Hepatic Disorders. Int J Res Pharm Sci. 2020;11(4):8194–200. Available from: http://dx.doi.org/10.26452/ ijrps.v11i4.1813
  19. Mashadi NS, Ghiasvand R, G A, M H, L D, Mofid MR. Antioxidative and Anti-Inflammatory Effects of Ginger in Health and Physical Activity: Review of Current Evidence. Int J Prev Med. 2013;36–42. Available from: https://api.semanticscholar. org/CorpusID:18384898
  20. Gupta, Manish Kumar, ketaki Dhane, Birendra Shrivasttva, Supriya Hyam SN. SHADDHARANA CHURNA: A POLYHERBAL FORMULATION. Front Biosci. 2022;27(2022):80–8.
  21. Timucin U. Mini Tablets: A Short Review-Revision. Open J Chem [Internet]. 2017 Jul 25;012–22. Available from: https:// peertechzpublications.org/articles/OJC-3-107.php
  22. Manish Kumar Gupta, Ketaki Dhane, Birendra Shrivasttva, Supriya Hyam, Sujit UNI-Directional Double Run Multi- Marker Based Standardization of “Amruthothram” Ayurvedic Medicine by HPTLC. Int J Res Pharm Sci. 2020;11(4):8216–21. Available from: https://doi.org/10.26452/ijrps.v11i4.1817
  23. Manish Kumar Gupta, Sujit Nagare, Birendra Shrivastava, Supriya Hyam, Ketaki Dhane. Preparation and Evaluation of Topical Polyherbal Emulgel Formulation for its Wound Healing Int J Res Pharm Sci. 2020;11(4):8181–6. Available from: https://doi.org/10.26452/ijrps.v11i4.1808
  24. Manish Kumar Gupta, Sujit Nagare, Birendra Shrivastava, Supriya Hyam, Ketaki Development and Evaluation of Topical Polyherbal Formulations for their Antimicrobial Potential. Int J Res Pharm Sci. 2020;11(4):8187–93. Available from: https://doi.org/10.26452/ijrps.v11i4.1812
  25. Pharmaceutical Post-Compression Evaluation Parameters for Tablets-an. 2022;4(March):526–30.
  26. Basu B, Bagadiya A, Makwana S, Vipul V, Batt D, Dharamsi Formulation and evaluation of fast dissolving tablets of cinnarizine using superdisintegrant blends and subliming J Adv Pharm Technol Res. 2011;2(4):266–73. Available from: https://doi.org/10.4103/2231-4040.90885
  27. Saleem M, Shahin M, Srinivas B, Begum Evaluation of Tablets by Friability Apparatus. Int J Res Pharm Chem. 2014;4(4):837–40. Available from: https://api.semanticscholar. org/CorpusID:212487322
  28. Mehmood Y, Shahid H, Abbas M, Farooq U, Ali S, Kazi M. Microsponge-derived mini tablets loaded with immunosuppressive agents: Pharmacokinetic investigation in human volunteers, cell viability and IVIVC correlation. Saudi Pharm J [Internet]. 2023;31(11):101799. Available from: https:// org/10.1016/j.jsps.2023.101799
  29. USP-NF. The United States pharmacopeia <701> Disintegration. United States Pharmacopeial Conv [Internet]. 2023;stage 4:2–5. Available from: https://usp.org/sites/default/files/usp/ document/harmonization/gen-chapter/april-2019-m99460.pdf
  30. Slovesnova N , Petrov AY, Glavatskih S, Bolotova V, Kopchuk DS. The Development of Tablets containing Vinpocetine and Ginkgo biloba L. Extract. Int J Drug Deliv Technol. 2023;13(4):1139–44. Available from: https://api.semanticscholar. org/CorpusID:267109325
  31. Mali DP, Kamble SP, Gaikwad DT, Wadkar GH, Bhutkar MA, Tamboli FA, et al. Standardization and Evaluation of Herbal Antihypertensive Sarpagandha (Reserpine) Tablet Int J Pharm Qual Assur. 2023;14(1):7–11. Available from: http:// dx.doi.org/10.25258/ijpqa.14.1.02
  32. Bai G, Armenante PM, Plank R , Gentzler M, Ford K, Harmon P. Hydrodynamic investigation of USP dissolution test apparatus II. J Pharm Sci. 2007;96(9):2327–49. Available from: https://doi. org/10.1002/jps.20818
  33. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694–702. Available from: https:// org/10.1016/0016-5085(90)90290-h
  34. Jeong J ju, Jang SE, Joh EH, Han MJ, Kim Kalopanaxsaponin B ameliorates TNBS-induced colitis in mice. Biomol Ther. 2012;20(5):457–62. Available from: https://doi.org/10.4062%2F biomolther.2012.20.5.457
  35. Park SY, Ku SK, Lee ES, Kim JA. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction. Chem Biol Interact [Internet]. 2012;196(1):39–49. Available from: https:// sciencedirect.com/science/article/pii/S0009279712000294
  36. Kim JY, Park BK, Park HJ, Park YH, Kim BO, Pyo S. Atopic dermatitis-mitigating effects of new Lactobacillus strain, Lactobacillus sakei probio 65 isolated from Kimchi. J Appl Microbiol. 2013;115(2):517–26. Available from: https://doi. org/10.1111/jam.12229
  37. Regmi SC, Park SY, Ku SK, Kim Serotonin regulates innate immune responses of colon epithelial cells through Nox2- derived reactive oxygen species. Free Radic Biol Med [Internet]. 2014;69:377–89. Available from: https://www.sciencedirect.com/ science/article/pii/S089158491400080X
  38. Zhao XP, Huang YY, Huang Y, Lei P, Peng JL, Wu S, et al. Transforming growth factor-Β1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells. Acta Pharmacol Sin [Internet]. 2010;31(3):347–54. Available from: http://dx.doi.org/10.1038/aps.2009.204